Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)NG101m Adjuvant Therapy in Glioblastoma Patients
Phase 1
Not yet recruiting
- Conditions
- Glioblastoma Multiforme
- Interventions
- First Posted Date
- 2020-05-04
- Last Posted Date
- 2023-04-18
- Lead Sponsor
- NeuGATE Theranostics
- Target Recruit Count
- 52
- Registration Number
- NCT04373785
- Locations
- 🇺🇸
Yvonne Kew MD, PLLC, Houston, Texas, United States
News
No news found